{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:57:40Z","timestamp":1792619860325,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jconrel.2024.01.011","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:39:09Z","timestamp":1706056749000},"page":"27-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease"],"prefix":"10.1016","volume":"367","author":[{"given":"Nicholas S.","family":"Caron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah E.-E.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Findlay Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale D.O.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandi E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo L.","family":"Casal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed M.R.","family":"Rahavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor S.D.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Stanimirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abedelnasser","family":"Abulrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.01.011_bb0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0015","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","article-title":"Cortical and striatal neurone number in Huntington\u2019s disease","volume":"88","author":"Heinsen","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101358","article-title":"Systemic manifestation and contribution of peripheral tissues to Huntington\u2019s disease pathogenesis","volume":"69","author":"Chuang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3959","article-title":"Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease","volume":"10","author":"Southwell","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0060","first-page":"36","article-title":"Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease","volume":"48","author":"Caron","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-022-28653-6","article-title":"An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion","volume":"13","author":"Keller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0070","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1038\/s41467-021-27157-z","article-title":"Small molecule splicing modifiers with systemic HTT-lowering activity","volume":"12","author":"Bhattacharyya","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb8920","article-title":"Widespread and sustained target engagement in Huntington\u2019s disease minipigs upon intrastriatal microRNA-based gene therapy","volume":"13","author":"Valles","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","article-title":"AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models","volume":"13","author":"Spronck","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0085","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.bcp.2008.11.005","article-title":"Cross-species comparison of in vivo PK\/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100","volume":"77","author":"Yu","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0105","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Phase 1-2a, Targeting Huntingtin Expression in Patients with Huntington's Disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnana.2014.00015","article-title":"Evolution of the human brain: when bigger is better","volume":"8","author":"Hofman","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1194\/jlr.M500531-JLR200","article-title":"Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I","volume":"47","author":"Duong","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0120","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","article-title":"Apolipoproteins in human cerebrospinal fluid","volume":"76","author":"Roheim","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dadm.2017.01.007","article-title":"Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma","volume":"6","author":"Koch","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0135","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0140","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1046\/j.1471-4159.1996.66062429.x","article-title":"Brain expression of apolipoproteins E, J, and A-I in Alzheimer\u2019s disease","volume":"66","author":"Harr","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0145","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.mp.4002108","article-title":"Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues","volume":"13","author":"Huang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0155","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.74.6.2569","article-title":"The intestine as a source of apolipoprotein A1","volume":"74","author":"Glickman","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.118.254201","article-title":"Apolipoprotein A-I crosses the blood-brain barrier through clathrin-independent and cholesterol-mediated endocytosis","volume":"369","author":"Zhou","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001156","article-title":"Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus","volume":"3","author":"Stukas","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of Caveolin, Clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jsbi.1998.4007","article-title":"Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer","volume":"123","author":"Bayburt","year":"1998","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/nl025623k","article-title":"Self-assembly of discoidal phospholipid bilayer nanoparticles with membrane scaffold proteins","volume":"2","author":"Bayburt","year":"2002","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0185","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/ja0393574","article-title":"Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size","volume":"126","author":"Denisov","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1194\/jlr.D500033-JLR200","article-title":"Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B","volume":"47","author":"Oda","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0195","doi-asserted-by":"crossref","first-page":"31755","DOI":"10.1074\/jbc.274.45.31755","article-title":"A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein","volume":"274","author":"Segrest","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0200","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1074\/jbc.274.21.14541","article-title":"The structure of human lipoprotein A-I. Evidence for the \u201cbelt\u201d model","volume":"274","author":"Koppaka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0205","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1529\/biophysj.106.087072","article-title":"Structural analysis of nanoscale self-assembled discoidal lipid bilayers by solid-state NMR spectroscopy","volume":"91","author":"Li","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0210","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1021\/bi050421z","article-title":"A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins","volume":"44","author":"Silva","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0215","doi-asserted-by":"crossref","first-page":"20418","DOI":"10.1074\/jbc.M602077200","article-title":"Apolipoprotein A-I assumes a \u201clooped belt\u201d conformation on reconstituted high density lipoprotein","volume":"281","author":"Martin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0220","doi-asserted-by":"crossref","first-page":"27199","DOI":"10.1074\/jbc.M302764200","article-title":"The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass specrometry study","volume":"278","author":"Davidson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0225","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1110\/ps.03267503","article-title":"Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers","volume":"12","author":"Bayburt","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0230","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2008.01.066","article-title":"Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles","volume":"377","author":"Banerjee","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nsmb.3195","article-title":"Nanodiscs for structural and functional studies of membrane proteins","volume":"23","author":"Denisov","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0240","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1529\/biophysj.104.046896","article-title":"Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins","volume":"88","author":"Shih","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0245","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.abb.2006.03.013","article-title":"Assembly of single bacteriorhodopsin trimers in bilayer nanodiscs","volume":"450","author":"Bayburt","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0250","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1073\/pnas.062565599","article-title":"Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks","volume":"99","author":"Bayburt","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","article-title":"Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL","volume":"84","author":"Zannis","year":"2006","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2010.07.057","article-title":"A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties","volume":"399","author":"Burgess","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0265","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/AAC.50.4.1238-1244.2006","article-title":"Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB\/c mice","volume":"50","author":"Nelson","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-2952(96)00170-0","article-title":"Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles","volume":"52","author":"Bijsterbosch","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0275","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nano.2010.08.002","article-title":"Curcumin nanodisks: formulation and characterization","volume":"7","author":"Ghosh","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0280","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijpharm.2007.02.033","article-title":"All-trans-retinoic acid nanodisks","volume":"339","author":"Redmond","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2010.08209.x","article-title":"All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma","volume":"150","author":"Singh","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0290","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3748\/wjg.v11.i7.954","article-title":"High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells","volume":"11","author":"Lou","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0295","first-page":"1365","article-title":"High-density lipoprotein-mimicking Nanodiscs for chemo-immunotherapy against glioblastoma Multiforme","volume":"13","author":"Kadiyala","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0300","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/bcb-2014-0027","article-title":"Cationic lipid nanodisks as an siRNA delivery vehicle","volume":"92","author":"Ghosh","year":"2014","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0305","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/hum.2010.083","article-title":"High-density lipoprotein facilitates in vivo delivery of alpha-tocopherol-conjugated short-interfering RNA to the brain","volume":"22","author":"Uno","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0310","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and optimization of in vivo delivery of lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/acs.bioconjchem.1c00505","article-title":"Gene regulation using Nanodiscs modified with HIF-1-alpha antisense oligonucleotides","volume":"33","author":"Sharma","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0320","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jconrel.2023.07.027","article-title":"Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks","volume":"360","author":"Aly","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0325","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0330","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1046-5928(02)00568-5","article-title":"Optimized bacterial expression of human apolipoprotein A-I","volume":"27","author":"Ryan","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0335","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/bi001922h","article-title":"Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity","volume":"40","author":"Oda","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0340","first-page":"2150","article-title":"Optimized negative-staining electron microscopy for lipoprotein studies","volume":"2013","author":"Zhang","year":"1830","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0355","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1523\/JNEUROSCI.1865-20.2020","article-title":"Mutant huntingtin is cleared from the brain via active mechanisms in Huntington disease","volume":"41","author":"Caron","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105652","article-title":"Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice","volume":"166","author":"Caron","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0365","doi-asserted-by":"crossref","first-page":"12166","DOI":"10.1038\/srep12166","article-title":"Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression","volume":"5","author":"Southwell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0370","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JHD-200463","article-title":"Reliable resolution of full-length huntingtin alleles by quantitative immunoblotting","volume":"10","author":"Caron","year":"2021","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0375","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1194\/jlr.M085332","article-title":"A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL","volume":"59","author":"Cooke","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0380","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0385","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/mp800032f","article-title":"Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution","volume":"5","author":"Dobrovolskaia","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0390","doi-asserted-by":"crossref","first-page":"48716","DOI":"10.1074\/jbc.M106265200","article-title":"The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo","volume":"276","author":"Scott","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0395","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0400","doi-asserted-by":"crossref","first-page":"26910","DOI":"10.1074\/jbc.270.45.26910","article-title":"Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability","volume":"270","author":"Sparks","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0405","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-2275(20)32402-0","article-title":"Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity","volume":"41","author":"Parks","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0410","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1074\/jbc.270.11.5882","article-title":"The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol","volume":"270","author":"Davidson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0415","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1139\/o2012-015","article-title":"Tweaking the cholesterol efflux capacity of reconstituted HDL","volume":"90","author":"Ma","year":"2012","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0420","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/acs.jctc.5b00668","article-title":"Molecular models of nanodiscs","volume":"11","author":"Siuda","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0425","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/S0021-9258(17)40217-1","article-title":"Structure and thermodynamic properties of high density lipoprotein recombinants","volume":"252","author":"Tall","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0430","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/bi00600a008","article-title":"Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines","volume":"17","author":"Pownall","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0435","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0440","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/S0021-9258(18)32955-7","article-title":"Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I","volume":"258","author":"Weisgraber","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(96)05982-5","article-title":"The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano","volume":"128","author":"Bruckert","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0450","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1997.6286","article-title":"Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer","volume":"232","author":"Calabresi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0455","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s001099900034","article-title":"Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux","volume":"77","author":"Daum","year":"1999","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sjostedt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0465","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-2275(20)31693-X","article-title":"Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI","volume":"42","author":"de Beer","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0475","doi-asserted-by":"crossref","first-page":"18897","DOI":"10.1074\/jbc.M002411200","article-title":"Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class a amphipathic alpha-helix as a recognition motif","volume":"275","author":"Williams","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0480","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.04-1711fje","article-title":"Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1","volume":"19","author":"Oshio","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152317","article-title":"Nanoparticle-induced immune response: health risk versus treatment opportunity?","volume":"228","author":"Pondman","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0490","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0495","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/bc980143z","article-title":"Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM","volume":"10","author":"Cheng","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0500","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0505","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.ATV.16.9.1203","article-title":"Effects of intravenous infusion of lipid-free apo A-I in humans","volume":"16","author":"Nanjee","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0510","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000089375.60050.35","article-title":"Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice","volume":"108","author":"Navab","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0515","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1194\/jlr.M060285","article-title":"The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties","volume":"56","author":"Schwendeman","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0520","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1096\/fj.09-139865","article-title":"RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe","volume":"24","author":"Chen","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0525","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2008.12.077","article-title":"Targeting nanodisks via a single chain variable antibody--apolipoprotein chimera","volume":"379","author":"Iovannisci","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4155\/tde.13.47","article-title":"Oligonucleotide conjugates for therapeutic applications","volume":"4","author":"Winkler","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0535","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.01.011_bb0540","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2024.01.011_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006846","article-title":"Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis","volume":"13","author":"Dietrich","year":"2017","journal-title":"PLoS Genet."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:48:46Z","timestamp":1759164526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":109,"alternative-id":["S0168365924000154"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}